| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
51,320,000 |
| Market
Cap: |
4.36(B) |
| Last
Volume: |
660,191 |
Avg
Vol: |
495,679 |
| 52
Week Range: |
$71.24 - $97.37 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P SMALLCAP 600 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 438 |
| Guru Rank Value : 3.1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Haemonetics is a global healthcare company providing a suite of medical products and solutions for customers. Co.'s technology addresses medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Co. has three principal reporting segments: Plasma, which provides automated plasma collection and donor management software systems; Blood Center, which provides a range of solutions that improve donor collection centers' ability to collect and filter blood and separate blood components; and Hospital, which has four product lines, including Hemostasis Management, Vascular Closure, Transfusion Management and Cell Salvage.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
31,812 |
31,812 |
52,026 |
112,537 |
| Total Sell Value |
$2,869,033 |
$2,869,033 |
$4,659,768 |
$9,356,099 |
| Total People Sold |
4 |
4 |
5 |
9 |
| Total Sell Transactions |
11 |
11 |
16 |
32 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Simon Christopher |
President & CEO |
• • – |
2019-05-23 |
4 |
S |
$99.39 |
$2,426,309 |
D/D |
(24,412) |
250,233 |
|
- |
|
| Simon Christopher |
President & CEO |
• • – |
2019-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
53,654 |
274,645 |
|
- |
|
| Kroll Mark W |
Director |
• • – |
2019-05-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,449 |
22,157 |
|
- |
|
| Bolorforosh Said |
EVP, Chief Technology Officer |
• • – |
2019-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,275 |
2,210 |
|
- |
|
| Llorens Josep |
SVP, Global Manufacturing |
• • – |
2019-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,530 |
2,871 |
|
- |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2019-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
573 |
3,192 |
|
- |
|
| Simon Christopher |
President & CEO |
• • – |
2019-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
14,027 |
220,991 |
|
- |
|
| Scanlan Jacqueline |
SVP, Global Human Resources |
• • – |
2019-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,530 |
5,990 |
|
- |
|
| Scanlan Jacqueline |
SVP, Global Human Resources |
• • – |
2019-05-14 |
4 |
AS |
$100.00 |
$150,800 |
D/D |
(1,508) |
4,237 |
|
- |
|
| Scanlan Jacqueline |
SVP, Global Human Resources |
• • – |
2019-05-14 |
4 |
OE |
$38.43 |
$49,921 |
D/D |
1,299 |
5,745 |
|
- |
|
| Burke Willaim P |
EVP, Chief Financial Officer |
• • – |
2019-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
3,060 |
15,061 |
|
- |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2019-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,805 |
15,684 |
|
- |
|
| Pomeroy Claire |
Director |
• • – |
2019-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
496 |
496 |
|
- |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2019-04-09 |
4 |
AS |
$88.99 |
$34,617 |
D/D |
(389) |
2,619 |
|
- |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2019-04-08 |
4 |
AS |
$88.31 |
$250,386 |
D/D |
(2,817) |
3,008 |
|
- |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2019-04-08 |
4 |
OE |
$34.42 |
$89,733 |
D/D |
2,607 |
5,825 |
|
- |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2019-03-07 |
4 |
S |
$83.57 |
$32,676 |
D/D |
(391) |
12,879 |
|
- |
|
| Scanlan Jacqueline |
SVP, Global Human Resources |
• • – |
2019-03-07 |
4 |
S |
$83.57 |
$9,694 |
D/D |
(116) |
4,446 |
|
- |
|
| Gelbman Ronald G |
Director |
• • – |
2019-02-15 |
4 |
S |
$86.52 |
$709,118 |
D/D |
(8,196) |
53,062 |
|
- |
|
| Gelbman Ronald G |
Director |
• • – |
2019-02-15 |
4 |
OE |
$36.37 |
$298,089 |
D/D |
8,196 |
61,258 |
|
- |
|
| Meelia Richard J |
Director |
• • – |
2018-12-14 |
4 |
S |
$102.86 |
$843,041 |
D/D |
(8,196) |
28,607 |
|
- |
|
| Meelia Richard J |
Director |
• • – |
2018-12-14 |
4 |
OE |
$36.37 |
$298,089 |
D/D |
8,196 |
36,803 |
|
- |
|
| Gelbman Ronald G |
Director |
• • – |
2018-12-14 |
4 |
S |
$103.02 |
$445,974 |
D/D |
(4,329) |
53,062 |
|
- |
|
| Scanlan Jacqueline |
SVP, Global Human Resources |
• • – |
2018-12-12 |
4 |
AS |
$104.22 |
$107,034 |
D/D |
(1,027) |
4,562 |
|
- |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2018-12-10 |
4 |
AS |
$102.91 |
$174,227 |
D/D |
(1,693) |
3,218 |
|
- |
|
1368 Records found
|
|
Page 15 of 55 |
|
|
0.92 (1.09%) 
